Page last updated: 2024-08-26

cp-55,940 and l 759633

cp-55,940 has been researched along with l 759633 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brockie, HC; Makriyannis, A; Murphy, VL; Pertwee, RG; Ross, RA; Stevenson, LA; Templeton, F	1
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A	1
Buzard, DJ; Han, S; Jones, RM; Thatte, J	1

Reviews

1 review(s) available for cp-55,940 and l 759633

Article	Year
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21 Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity	2013

Other Studies

2 other study(ies) available for cp-55,940 and l 759633

Article	Year
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. British journal of pharmacology, 1999, Volume: 126, Issue:3 Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium	1999
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism	2011

Article

Year

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

British journal of pharmacology, 1999, Volume: 126, Issue:3

Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium

1999

Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.

European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism

2011